Asthma News – September 12 to 17, 2018
Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services Asthma Program Staff.
A retrospective analysis of data from patients with severe asthma who participated in the COBRA trial identified key clinical characteristics that may help clinicians recognize patients who may benefit from additional targeted drug therapy, such as benralizumab.
The Guide was developed to help all school personnel, parents/guardians, health care providers and school boards support students with asthma. This document provides information about asthma, how to manage it at school, and how to create an asthma-friendly school building.
Using the NHANES database, researchers found that the ACO group represents an important subset of patients with chronic respiratory disease, with an increased burden of disease over asthma and COPD individually.
The combination of montelukast and budesonide was found more effective than budesonide alone in children with chronic cough variant asthma, in a recent retrospective study conducted in China.
In inner city children, patterns of wheezing, lung function, and allergic sensitization identified 5 respiratory phenotypes that can help to elucidate the contributions of environmental risk factors to distinct forms of childhood asthma, according to a new study.
Analyzing data on more than 8,600 non-obese people from 12 countries, researchers found that about 10% of those who had asthma when the study began were obese 10 years later. The same was true for only about 8% of those who didn't initially have asthma.
A study of over 300 severe asthmatics found their sputum samples were more than twice as likely to have more eosinophils in morning clinics than in the afternoon. Levels of eosinophils—a biomarker in sputum—are used to guide treatment in severe asthma patients.